1. Home
  2. SLND vs TELO Comparison

SLND vs TELO Comparison

Compare SLND & TELO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLND
  • TELO
  • Stock Information
  • Founded
  • SLND 1900
  • TELO 2021
  • Country
  • SLND United States
  • TELO United States
  • Employees
  • SLND N/A
  • TELO N/A
  • Industry
  • SLND Military/Government/Technical
  • TELO
  • Sector
  • SLND Industrials
  • TELO
  • Exchange
  • SLND Nasdaq
  • TELO NYSE
  • Market Cap
  • SLND 151.1M
  • TELO 124.1M
  • IPO Year
  • SLND N/A
  • TELO 2024
  • Fundamental
  • Price
  • SLND $3.61
  • TELO $5.18
  • Analyst Decision
  • SLND Buy
  • TELO
  • Analyst Count
  • SLND 2
  • TELO 0
  • Target Price
  • SLND $5.50
  • TELO N/A
  • AVG Volume (30 Days)
  • SLND 42.3K
  • TELO 341.4K
  • Earning Date
  • SLND 11-12-2024
  • TELO 02-12-2025
  • Dividend Yield
  • SLND N/A
  • TELO N/A
  • EPS Growth
  • SLND N/A
  • TELO N/A
  • EPS
  • SLND N/A
  • TELO N/A
  • Revenue
  • SLND $1,029,117,999.00
  • TELO N/A
  • Revenue This Year
  • SLND $0.91
  • TELO N/A
  • Revenue Next Year
  • SLND $5.38
  • TELO N/A
  • P/E Ratio
  • SLND N/A
  • TELO N/A
  • Revenue Growth
  • SLND N/A
  • TELO N/A
  • 52 Week Low
  • SLND $1.85
  • TELO $3.11
  • 52 Week High
  • SLND $6.16
  • TELO $20.72
  • Technical
  • Relative Strength Index (RSI)
  • SLND 59.27
  • TELO 53.91
  • Support Level
  • SLND $3.37
  • TELO $4.50
  • Resistance Level
  • SLND $3.63
  • TELO $5.39
  • Average True Range (ATR)
  • SLND 0.25
  • TELO 0.67
  • MACD
  • SLND 0.02
  • TELO -0.05
  • Stochastic Oscillator
  • SLND 91.46
  • TELO 30.41

About SLND Southland Holdings Inc.

Southland Holdings Inc is an infrastructure construction company in North America. The company's infrastructure projects range from water conveyance systems and tunnels to long-span bridges and vertical structures.

About TELO TELOMIR PHARMACEUTICALS INC

Telomir Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic treatment for human stem cells.

Share on Social Networks: